+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07816692

Observational Study Evaluating Safety of iDose TR Travoprost Implant in Office-Based Surgery for Open-Angle Glaucoma and Ocular Hypertension

Led by Glaukos Corporation · Updated on 2026-09-30

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an observational study to evaluate the safety of the iDose TR travoprost intracameral implant when administered in an office-based surgery setting. This study involves adults diagnosed with open-angle glaucoma or ocular hypertension. The main goal is to observe how safely this implant can be given outside of a hospital operating room. Participants will receive the iDose TR implant, which releases travoprost, using a sterile preloaded inserter designed for single use. This is a single-arm, open-label trial carried out across multiple centers. The implant procedure will be performed in an office-based surgical environment rather than a traditional surgical facility. During the study, participants will be monitored to assess the successful administration of the implant over a period of three months. Researchers will evaluate safety outcomes, including any adverse events related to the implant or procedure. The study will involve regular follow-up visits to track participant outcomes and ensure proper monitoring. Total participation lasts up to three months from the time of implant administration.

CONDITIONS

Brief Title

iDose TR Administration in an Office-Based Surgery Setting

Research Team

S

Study Director

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here